The Impact of Emerging Infectious Diseases on Chinese Blood Safety

Miao He, Jingxing Wang, Limin Chen, Jing Liu, Peibin Zeng

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Emerging infectious diseases (EIDs) have always been one of the major threats to public health. Although the implementation of mandatory testing for 4 classical transfusion-transmitted infectious—human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis—has reduced the transfusion risk of these pathogens, the potential threat of various EID agents and their constantly evolving variants to blood safety in China is not fully understood. This review presents 9 representative EID agents that are autochthonous and epidemic nationally or regionally in China. The epidemiologic status and distribution of these EID agents among donors and/or healthy populations are summarized. The potential risks of these EID agents to blood safety are discussed. The review also explores strategies to strengthen hemovigilance systems and studies to further evaluate the impact of EID agents on blood safety.

Original languageEnglish (US)
Pages (from-to)94-101
Number of pages8
JournalTransfusion medicine reviews
Issue number2
StatePublished - Apr 1 2017


  • Chinese blood safety
  • Emerging infectious diseases
  • Transfusion-transmitted infectious

ASJC Scopus subject areas

  • Hematology
  • Clinical Biochemistry
  • Biochemistry, medical


Dive into the research topics of 'The Impact of Emerging Infectious Diseases on Chinese Blood Safety'. Together they form a unique fingerprint.

Cite this